Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer (FOGT1)

This study has been completed.
Sponsor:
Collaborators:
Medac GmbH (Hamburg, Germany)
Roche (Grenzach-Wyhlen, Germany)
Information provided by:
University of Ulm
ClinicalTrials.gov Identifier:
NCT01060501
First received: February 1, 2010
Last updated: NA
Last verified: July 1991
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)